Literature DB >> 1719534

Identification of a continuous and cross-reacting epitope for Plasmodium falciparum transmission-blocking immunity.

B Wizel1, N Kumar.   

Abstract

Identification of continuous epitopes in the target antigens of Plasmodium falciparum transmission-blocking antibodies is likely to facilitate the production of a subunit peptide vaccine. Two such epitopes shared among several sexual-stage antigens were identified with murine monoclonal antibodies. An epitope recognized by four monoclonal antibodies capable of blocking infectivity of gametocytes in the mosquitoes is shared among three antigens (230, 48/45 doublet, and 27 kDa). These antigens are synthesized at different times during the development and maturation of gametocytes, and the blocking epitope appears conserved among parasites from diverse geographical locations. Immune response against such a unique epitope (continuous, cross-reacting, and conserved) is likely to be boosted by natural infection. The 27-kDa protein is reported here as a target of malaria transmission-blocking monoclonal antibodies, and the cross-reacting epitope represents an attractive candidate for a transmission-blocking vaccine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719534      PMCID: PMC52752          DOI: 10.1073/pnas.88.21.9533

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation.

Authors:  M F Good; S Kumar; L H Miller
Journal:  Immunol Today       Date:  1988-11

2.  The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies.

Authors:  I A Quakyi; R Carter; J Rener; N Kumar; M F Good; L H Miller
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

Review 3.  Immunity to sexual stages of malaria parasites.

Authors:  R Carter; N Kumar; I Quakyi; M Good; K Mendis; P Graves; L Miller
Journal:  Prog Allergy       Date:  1988

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The primary antibody response of malaria patients to Plasmodium falciparum sexual stage antigens which are potential transmission blocking vaccine candidates.

Authors:  C S Ong; K Y Zhang; S J Eida; P M Graves; C Dow; M Looker; N C Rogers; P L Chiodini; G A Targett
Journal:  Parasite Immunol       Date:  1990-09       Impact factor: 2.280

6.  Phase separation in Triton X-114 of antigens of transmission blocking immunity in Plasmodium gallinaceum.

Authors:  N Kumar
Journal:  Mol Biochem Parasitol       Date:  1985-12       Impact factor: 1.759

7.  Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera.

Authors:  P M Graves; R Carter; T R Burkot; I A Quakyi; N Kumar
Journal:  Parasite Immunol       Date:  1988-03       Impact factor: 2.280

8.  Genetic analysis of the human malaria parasite Plasmodium falciparum.

Authors:  D Walliker; I A Quakyi; T E Wellems; T F McCutchan; A Szarfman; W T London; L M Corcoran; T R Burkot; R Carter
Journal:  Science       Date:  1987-06-26       Impact factor: 47.728

9.  Biosynthesis of two stage-specific membrane proteins during transformation of Plasmodium gallinaceum zygotes into ookinetes.

Authors:  N Kumar; R Carter
Journal:  Mol Biochem Parasitol       Date:  1985-02       Impact factor: 1.759

10.  Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito.

Authors:  A N Vermeulen; T Ponnudurai; P J Beckers; J P Verhave; M A Smits; J H Meuwissen
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

View more
  8 in total

1.  Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodies.

Authors:  C A Lobo; R Dhar; N Kumar
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Mapping of specific and promiscuous HLA-DR-restricted T-cell epitopes on the Plasmodium falciparum 27-kilodalton sexual stage-specific antigen.

Authors:  C E Contreras; I N Ploton; R F Siliciano; C L Karp; R Viscidi; N Kumar
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

3.  Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230.

Authors:  J Healer; D McGuinness; P Hopcroft; S Haley; R Carter; E Riley
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  Anopheles gambiae salivary gland proteins as putative targets for blocking transmission of malaria parasites.

Authors:  J D Brennan; M Kent; R Dhar; H Fujioka; N Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

5.  Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine.

Authors:  Y P Shi; S E Hasnain; J B Sacci; B P Holloway; H Fujioka; N Kumar; R Wohlhueter; S L Hoffman; W E Collins; A A Lal
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

6.  Plasmodium falciparum phosphoethanolamine methyltransferase is essential for malaria transmission.

Authors:  April M Bobenchik; William H Witola; Yoann Augagneur; Laura Nic Lochlainn; Aprajita Garg; Niseema Pachikara; Jae-Yeon Choi; Yang O Zhao; Sahar Usmani-Brown; Albert Lee; Sophie H Adjalley; Swapna Samanta; David A Fidock; Dennis R Voelker; Erol Fikrig; Choukri Ben Mamoun
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

7.  Plasmodium falciparum enolase: stage-specific expression and sub-cellular localization.

Authors:  Ipsita Pal Bhowmick; Nirbhay Kumar; Shobhona Sharma; Isabelle Coppens; Gotam K Jarori
Journal:  Malar J       Date:  2009-07-30       Impact factor: 2.979

8.  Pfs2400 can mediate antibody-dependent malaria transmission inhibition and may be the Plasmodium falciparum 11.1 gene product.

Authors:  Z Feng; R N Hoffmann; R S Nussenzweig; M Tsuji; H Fujioka; M Aikawa; T H Lensen; T Ponnudurai; L G Pologe
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.